Understanding the long-term effects of treatment in Hodgkin lymphoma patients
Modeling Multi-Source Data in Hodgkin Lymphoma
This study is looking at how treatments for Hodgkin lymphoma might affect your health in the long run, especially regarding risks for other cancers and heart problems, using information from over 12,000 patients to help understand these effects better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11046511 on NIH RePORTER |
What this research studies
This research investigates the long-term health impacts of Hodgkin lymphoma treatments, focusing on late effects such as secondary cancers and cardiovascular diseases. By utilizing data from over 12,000 patients across multiple clinical trials and registries, the study aims to create a comprehensive model that links treatment outcomes with patient health over time. The approach involves collaboration among experts in oncology, epidemiology, and data science to analyze and harmonize patient data for better insights into post-treatment morbidity and survival.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who have been treated for Hodgkin lymphoma and are currently undergoing active follow-up care.
Not a fit: Patients who have not received treatment for Hodgkin lymphoma or those who are not in the active follow-up phase may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies that minimize long-term health risks for Hodgkin lymphoma survivors.
How similar studies have performed: Previous research has successfully utilized similar data modeling approaches to understand long-term outcomes in cancer patients, indicating a promising potential for this study.
Where this research is happening
Boston, United States
- Tufts Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Parsons, Susan Kenyon — Tufts Medical Center
- Study coordinator: Parsons, Susan Kenyon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.